News Highlights: Top Company News of the Day - Thursday at 7 AM ET

Dow Jones12-19
 
The RealReal Keeps Its Designer Sales Flowing as Overall Luxury Market Stalls 
 

The luxury resale platform is investing in AI technology to cut the time and cost it takes to prepare Chanel bags, Rolex watches and more for sale.

 
Apple Faults Meta For Software-Access Requests as EU Crackdown Looms 
 

Apple called out Meta for seeking access to software tools that it said could compromise user privacy, a criticism that comes as the EU tries to force the iPhone maker to give developers greater access to its technology.

 
The Risky Strategy Behind Nike's Massive Holiday Discounts 
 

The sneaker giant's new CEO is trying to clear out inventory, pressuring retailer partners.

 
FedEx Earnings Could Be Dwarfed by Potential Spinout of its Freight Business 
 

Investors also will be looking for a solid report and clues about the health of the U.S. economy.

 
Micron Stock Tumbles After Earnings Beat. What's Driving the Fall. 
 

Micron stock fell sharply Wednesday after the company forecast disappointing revenue for its current quarter.

 
Real Estate Manager Lafayette Settles Covid Fraud Case 
 

The $1 billion private investment firm counts Carlyle Group as a partner.

 
Volkswagen and Unions Enter Fourth Day of Talks 
 

Intensive negotiation between Volkswagen and labor leaders continue over how to proceed with cost cuts at the auto giant.

 
Sony to Raise Stake in Kadokawa, Becoming a Top Shareholder 
 

Sony Group plans to acquire an additional stake in Japanese publishing house Kadokawa for more than $300 million to become one of its largest shareholders.

 
Ant Group Warns Against 'False' IPO Rumors 
 

The Chinese fintech company, co-founded by billionaire Jack Ma, said it has no plans to go public, striking back at social-media posts contending the company was exploring a potential backdoor listing.

 
DOJ Alleges CVS Knowingly Contributed to Opioid Crisis in Suit 
 

CVS ignored substantial evidence from multiple sources including its own pharmacists and internal data that indicated its stores were dispensing unlawful prescriptions, the complaint alleges.

 
 

(END) Dow Jones Newswires

December 19, 2024 07:00 ET (12:00 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment